We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMarstons Regulatory News (MARS)

Share Price Information for Marstons (MARS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 27.20
Bid: 27.20
Ask: 27.25
Change: -0.05 (-0.18%)
Spread: 0.05 (0.184%)
Open: 27.00
High: 27.25
Low: 27.00
Prev. Close: 27.25
MARS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Dimensional Fund Advisors Ltd. : Form 8.3 - MARSTON'S PLC - Ordinary Shares

8 Feb 2021 11:14

Dimensional Fund Advisors Ltd. : Form 8.3 - MARSTON'S PLC - Ordinary Shares

FORM 8.3

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”)

1. KEY INFORMATION

(a) Full name of discloser: Dimensional Fund Advisors Ltd. (“Dimensional”), in its capacity as investment manager and on behalf its affiliates who are also investment managers. Dimensional and its affiliates expressly disclaim beneficial ownership of the shares described in this form 8.3
(b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.  
(c) Name of offeror/offeree in relation to whose relevant securities this form relates: Use a separate form for each offeror/offeree Marston’s plc(GB00B1JQDM80)
(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:  
(e) Date position held/dealing undertaken: For an opening position disclosure, state the latest practicable date prior to the disclosure 5 February 2021
(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer? If it is a cash offer or possible cash offer, state “N/A” N/A If YES, specify which:

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

Class of relevant security:  7.375p Ordinary Shares
 Interests Short positions
 Number % Number %
(1) Relevant securities owned and/or controlled: 31,546,079* 4.98%    
(2) Cash-settled derivatives:         
(3) Stock-settled derivatives (including options) and agreements to purchase/sell:        
TOTAL: 31,546,079 4.98%    

*Dimensional Fund Advisors Ltd. and / or its affiliates do not control voting discretion for 1,067,742 shares.

All interests and all short positions should be disclosed.

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

(b) Rights to subscribe for new securities (including directors’ and other employee options)

Class of relevant security in relation to which subscription right exists:  
Details, including nature of the rights concerned and relevant percentages:  

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

The currency of all prices and other monetary amounts should be stated.

(a) Purchases and sales

Class of relevant security Purchase/sale  Number of securities Price per unit
Ordinary shares Sale 119,633 GBP 0.9927

 (b) Cash-settled derivative transactions

Class of relevant security Product descriptione.g. CFD Nature of dealinge.g. opening/closing a long/short position, increasing/reducing a long/short position Number of reference securities Price per unit
         

(c) Stock-settled derivative transactions (including options)

(i) Writing, selling, purchasing or varying

Class of relevant security Product description e.g. call option Writing, purchasing, selling, varying etc. Number of securities to which option relates Exercise price per unit Typee.g. American, Eropean etc. Expiry date Option money paid/ received per unit
               

(ii) Exercise

Class of relevant security Product descriptione.g. call option Exercising/ exercised against Number of securities Exercise price per unit
         

(d) Other dealings (including subscribing for new securities)

Class of relevant security Nature of dealinge.g. subscription, conversion Details Price per unit (if applicable)
       

4. OTHER INFORMATION

(a) Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state “none”

(b) Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:(i) the voting rights of any relevant securities under any option; or (ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:If there are no such agreements, arrangements or understandings, state “none”

(c) Attachments

Is a Supplemental Form 8 (Open Positions) attached? NO

Date of disclosure: 8 February 2021
Contact name: Thomas Hone
Telephone number: 020 3033 3419

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at monitoring@disclosure.org.uk. The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s disclosure requirements on +44 (0)20 7638 0129.

The Code can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk.

Date   Source Headline
28th Mar 20242:50 pmRNSDirector/PDMR Shareholding
15th Mar 202410:15 amRNSDirector/PDMR Shareholding
11th Mar 20247:00 amRNSSuccession plan to appoint new Chair of the Board
7th Mar 202410:03 amRNSDirector Declaration
6th Mar 20248:35 amRNSDirector/PDMR Shareholding
5th Mar 20244:24 pmRNSDirector/PDMR Shareholding
1st Mar 202412:58 pmRNSTotal Voting Rights
9th Feb 20248:40 amRNSHolding(s) in Company
7th Feb 20244:08 pmRNSHolding(s) in Company
2nd Feb 202411:14 amRNSDirector/PDMR Shareholding
1st Feb 20244:26 pmRNSHolding(s) in Company
31st Jan 20241:52 pmRNSHolding(s) in Company
23rd Jan 20241:30 pmRNSResult of AGM
23rd Jan 20247:00 amRNSTrading for the 16-week period to 20 January 2024
9th Jan 20241:57 pmRNSBlock listing Interim Review
20th Dec 20234:16 pmRNSAnnual Financial Report
5th Dec 20237:00 amRNSPRELIMINARY RESULTS
1st Dec 20232:30 pmRNSHolding(s) in Company
27th Nov 20237:00 amRNSDirectorate Change
22nd Nov 20232:02 pmRNSHolding(s) in Company
17th Nov 20237:00 amRNSMarston’s PLC appoints Justin Platt as new CEO
11th Oct 20237:00 amRNSTrading update for the 52 weeks to 30 Sep 2023
15th Aug 20233:36 pmRNSHolding(s) in Company
1st Aug 20239:30 amRNSHolding(s) in Company
26th Jul 20234:29 pmRNSHolding(s) in Company
26th Jul 20237:00 amRNSTrading update for the 42 weeks to 22 July 2023
10th Jul 20233:21 pmRNSBlock listing Interim Review
4th Jul 20232:18 pmRNSNotification of Trading Update Date
29th Jun 202310:26 amRNSDirector/PDMR Shareholding
28th Jun 20235:03 pmRNSDirector/PDMR Shareholding
28th Jun 20234:54 pmRNSDirector/PDMR Shareholding
27th Jun 20234:11 pmRNSDirector/PDMR Shareholding
26th Jun 20232:23 pmRNSDirector/PDMR Shareholding
26th Jun 20231:08 pmRNSDirector/PDMR Shareholding
25th May 20238:16 amRNSDirector/PDMR Shareholding
24th May 20238:48 amRNSDirector/PDMR Shareholding
16th May 20237:00 amRNSRESULTS FOR THE 26 WEEKS ENDED 1 APRIL 2023
31st Mar 20237:00 amRNSAmendment and extension of debt facilities
22nd Mar 202310:19 amRNSHolding(s) in Company
24th Jan 20232:01 pmRNSResult of AGM
24th Jan 20237:00 amRNSTrading for the 16-week period to 21 January 2023
10th Jan 20233:07 pmRNSBlock listing Interim Review
6th Jan 20233:11 pmRNSHolding(s) in Company
3rd Jan 20239:42 amRNSHolding(s) in Company
21st Dec 20225:05 pmRNSConfirmation of Covenant Amendments
21st Dec 20222:34 pmRNSAnnual Financial Report
14th Dec 20229:00 amRNSDirector/PDMR Shareholding
6th Dec 20227:00 amRNSPreliminary Results for 52 weeks ended 1 Oct 2022
5th Dec 202212:31 pmRNSConfirmation of Final Results announcement date
30th Nov 202210:46 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.